Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Dysphemia
ADR ID BADD_A05362
ADR Hierarchy
19      Psychiatric disorders
19.19      Communication disorders and disturbances
19.19.03      Speech articulation and rhythm disturbances
19.19.03.005      Dysphemia
17      Nervous system disorders
17.02      Neurological disorders NEC
17.02.08      Speech and language abnormalities
17.02.08.010      Dysphemia
Description A disturbance in the normal fluency and time patterning of speech that is inappropriate for the individual's age. This disturbance is characterized by frequent repetitions or prolongations of sounds or syllables. Various other types of speech dysfluencies may also be involved including interjections, broken words, audible or silent blocking, circumlocutions, words produced with an excess of physical tension, and monosyllabic whole word repetitions. Stuttering may occur as a developmental condition in childhood or as an acquired disorder which may be associated with BRAIN INFARCTIONS and other BRAIN DISEASES. (From DSM-IV, 1994) [MeSH]
MedDRA Code 10054964
MeSH ID D013342; D000067454
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Stammer | Stammer & stutter | Stammering | Stammering and stuttering | Stutter | Stuttering | Syllable stumbing | Syllable stumbling | Stammering aggravated | Dysphemia | Childhood-onset fluency disorder | Stuttering, Familial Persistent 1 | Stuttering, Developmental | Developmental Stuttering | Stuttering, Adult | Adult Stuttering | Stuttering, Childhood | Childhood Stuttering | Stuttering, Acquired | Acquired Stuttering
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01888Quetiapine--
BADD_D01889Quetiapine fumarate--
BADD_D01951Risperidone0.000182%
BADD_D01961Rofecoxib--
BADD_D02010Sertraline0.000079%
BADD_D02165Teriflunomide0.001881%
BADD_D02247Topiramate0.000050%
BADD_D02329Valproic acid0.000369%
BADD_D02337Varenicline0.000428%
BADD_D02346Venlafaxine--
BADD_D02396Zonisamide0.000622%
BADD_D02440Lisdexamfetamine0.000389%
BADD_D02451Pimavanserin0.000287%
BADD_D02464Fingolimod0.001953%
BADD_D02468Cannabidiol0.000697%
BADD_D02484Istradefylline0.001247%
BADD_D02491Valbenazine0.003661%
BADD_D02492Deflazacort0.000117%
BADD_D02507Deutetrabenazine0.001830%
BADD_D02565Lumateperone0.000510%
The 2th Page    First    Pre   2    Total 2 Pages